JNK inhibition arrests cotranslational degradation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 7, 2010, Pages 826-831

  Gandin, Valentina ^a   Brina, Daniela ^a   Marchisio, Pier Carlo ^a,b   Biffo, Stefano ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

EIF2; EIF4E; Fibronectin; Polysomes; Proteasome; Spreading

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; FIBRONECTIN; INITIATION FACTOR 2ALPHA; METHIONINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FIBROBLAST; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTHRACENES; CELL ADHESION; CELL LINE; CHROMONES; CYTOSKELETON; ENZYME INHIBITORS; FIBROBLASTS; FIBRONECTINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MORPHOLINES; NIH 3T3 CELLS; PROTEIN BIOSYNTHESIS;

EUKARYOTA;

EID: 77953358964     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.03.016     Document Type: Article

References (51)

1. Stupack D.G. The biology of integrins. Oncology (Williston Park) 2007, 21:6-12.
2. Marastoni S., Ligresti G., Lorenzon E., Colombatti A., Mongiat M. Extracellular matrix: a matter of life and death. Connect. Tissue Res. 2008, 49:203-206.
3. Arnaout M.A., Goodman S.L., Xiong J.P. Structure and mechanics of integrin-based cell adhesion. Curr. Opin. Cell Biol. 2007, 19:495-507.
4. Leiss M., Beckmann K., Giros A., Costell M., Fassler R. The role of integrin binding sites in fibronectin matrix assembly in vivo. Curr. Opin. Cell Biol. 2008, 20:502-507.
5. Delon I., Brown N.H. Integrins and the actin cytoskeleton. Curr. Opin. Cell Biol. 2007, 19:43-50.
6. Calderwood D.A., Shattil S.J., Ginsberg M.H. Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling. J. Biol. Chem. 2000, 275:22607-22610.
7. Juliano R.L., Reddig P., Alahari S., Edin M., Howe A., Aplin A. Integrin regulation of cell signalling and motility. Biochem. Soc. Trans. 2004, 32:443-446.
8. Maeshima Y., Sudhakar A., Lively J.C., Ueki K., Kharbanda S., Kahn C.R., Sonenberg N., Hynes R.O., Kalluri R. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 2002, 295:140-143.
9. Pabla R., Weyrich A.S., Dixon D.A., Bray P.F., McIntyre T.M., Prescott S.M., Zimmerman G.A. Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J. Cell Biol. 1999, 144:175-184.
10. Chung J., Bachelder R.E., Lipscomb E.A., Shaw L.M., Mercurio A.M. Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J. Cell Biol. 2002, 158:165-174.
11. Folgiero V., Bachelder R.E., Bon G., Sacchi A., Falcioni R., Mercurio A.M. The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6beta4 signaling and function. Cancer Res. 2007, 67:1645-1652.
12. Gorrini C., Loreni F., Gandin V., Sala L.A., Sonenberg N., Marchisio P.C., Biffo S. Fibronectin controls cap-dependent translation through beta1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9200-9205.
13. Fu Y., Wang L.Y., Liang Y.L., Jin J.W., Fang Z.Y., Zha X.L. Integrin beta(1A) upregulates p27 protein amount at the post-translational level in human hepatocellular carcinoma cell line SMMC-7721. Acta Biochim. Biophys. Sin. (Shanghai) 2006, 38:523-530.
14. Sonenberg N., Hinnebusch A.G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009, 136:731-745.
15. Gebauer F., Hentze M.W. Molecular mechanisms of translational control. Nat. Rev. Mol. Cell Biol. 2004, 5:827-835.
16. Gingras A.C., Raught B., Gygi S.P., Niedzwiecka A., Miron M., Burley S.K., Polakiewicz R.D., Wyslouch-Cieszynska A., Aebersold R., Sonenberg N. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 2001, 15:2852-2864.
17. Haghighat A., Mader S., Pause A., Sonenberg N. Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J. 1995, 14:5701-5709.
18. Gingras A.C., Kennedy S.G., O'Leary M.A., Sonenberg N., Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 1998, 12:502-513.
19. Hara K., Yonezawa K., Kozlowski M.T., Sugimoto T., Andrabi K., Weng Q.P., Kasuga M., Nishimoto I., Avruch J. Regulation of eIF-4E BP1 phosphorylation by mTOR. J. Biol. Chem. 1997, 272:26457-26463.
20. Ueda T., Watanabe-Fukunaga R., Fukuyama H., Nagata S., Fukunaga R. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol. Cell. Biol. 2004, 24:6539-6549.
21. Morley S.J., McKendrick L. Involvement of stress-activated protein kinase and p38/RK mitogen-activated protein kinase signaling pathways in the enhanced phosphorylation of initiation factor 4E in NIH 3T3 cells. J. Biol. Chem. 1997, 272:17887-17893.
22. Silva R.L., Wendel H.G. MNK, EIF4E and targeting translation for therapy. Cell. Cycle 2008, 7:553-555.
23. Severini M., Spurio R., La Teana A., Pon C.L., Gualerzi C.O. Ribosome-independent GTPase activity of translation initiation factor IF2 and of its G-domain. J. Biol. Chem. 1991, 266:22800-22802.
24. Kapp L.D., Lorsch J.R. GTP-dependent recognition of the methionine moiety on initiator tRNA by translation factor eIF2. J. Mol. Biol. 2004, 335:923-936.
25. Krishnamoorthy T., Pavitt G.D., Zhang F., Dever T.E., Hinnebusch A.G. Tight binding of the phosphorylated alpha subunit of initiation factor 2 (eIF2alpha) to the regulatory subunits of guanine nucleotide exchange factor eIF2B is required for inhibition of translation initiation. Mol. Cell. Biol. 2001, 21:5018-5030.
26. Sudhakar A., Ramachandran A., Ghosh S., Hasnain S.E., Kaufman R.J., Ramaiah K.V. Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry 2000, 39:12929-12938.
27. Jiang H.Y., Wek R.C. Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J. Biol. Chem. 2005, 280:14189-14202.
28. Koumenis C., Naczki C., Koritzinsky M., Rastani S., Diehl A., Sonenberg N., Koromilas A., Wouters B.G. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol. Cell. Biol. 2002, 22:7405-7416.
29. Hamanaka R.B., Bennett B.S., Cullinan S.B., Diehl J.A. PERK and GCN2 contribute to eIF2alpha phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway. Mol. Biol. Cell 2005, 16:5493-5501.
30. Wek R.C., Cavener D.R. Translational control and the unfolded protein response. Antioxid. Redox Signal. 2007, 9:2357-2371.
31. Vembar S.S., Brodsky J.L. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell Biol. 2008, 9:944-957.
32. Schubert U., Anton L.C., Gibbs J., Norbury C.C., Yewdell J.W., Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000, 404:770-774.
33. Qian S.B., Princiotta M.F., Bennink J.R., Yewdell J.W. Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control. J. Biol. Chem. 2006, 281:392-400.
34. Kallunki T., Su B., Tsigelny I., Sluss H.K., Derijard B., Moore G., Davis R., Karin M. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 1994, 8:2996-3007.
35. Topisirovic I., Gutierrez G.J., Chen M., Appella E., Borden K.L., Ronai Z.A. Control of p53 multimerization by Ubc13 is JNK-regulated. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12676-12681.
36. Biffo S., Sanvito F., Costa S., Preve L., Pignatelli R., Spinardi L., Marchisio P.C. Isolation of a novel beta4 integrin-binding protein (p27(BBP)) highly expressed in epithelial cells. J. Biol. Chem. 1997, 272:30314-30321.
37. Sanvito F., Piatti S., Villa A., Bossi M., Lucchini G., Marchisio P.C., Biffo S. The beta4 integrin interactor p27(BBP/eIF6) is an essential nuclear matrix protein involved in 60S ribosomal subunit assembly. J. Cell Biol. 1999, 144:823-837.
38. Gandin V., Miluzio A., Barbieri A.M., Beugnet A., Kiyokawa H., Marchisio P.C., Biffo S. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation. Nature 2008, 455:684-688.
39. 1 phase of the cell cycle. J. Cell Biol. 1999, 145:1461-1469.
40. Xia Y., Karin M. The control of cell motility and epithelial morphogenesis by Jun kinases. Trends Cell Biol. 2004, 14:94-101.
41. Huang C., Rajfur Z., Borchers C., Schaller M.D., Jacobson K. JNK phosphorylates paxillin and regulates cell migration. Nature 2003, 424:219-223.
42. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13681-13686.
43. Kimball S.R. Eukaryotic initiation factor eIF2. Int. J. Biochem. Cell Biol. 1999, 31:25-29.
44. Urano F., Wang X., Bertolotti A., Zhang Y., Chung P., Harding H.P., Ron D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000, 287:664-666.
45. Liang S.H., Zhang W., McGrath B.C., Zhang P., Cavener D.R. PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis. Biochem. J. 2006, 393:201-209.
46. Fornaro M., Steger C.A., Bennett A.M., Wu J.J., Languino L.R. Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/mitogen-activated protein kinase pathways. Mol. Biol. Cell 2000, 11:2235-2249.
47. Wang X., Flynn A., Waskiewicz A.J., Webb B.L., Vries R.G., Baines I.A., Cooper J.A., Proud C.G. The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J. Biol. Chem. 1998, 273:9373-9377.
48. Topisirovic I., Ruiz-Gutierrez M., Borden K.L. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities. Cancer Res. 2004, 64:8639-8642.
49. Bianchini A., Loiarro M., Bielli P., Busa R., Paronetto M.P., Loreni F., Geremia R., Sette C. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells. Carcinogenesis 2008, 29:2279-2288.
50. Zhang Y., Li Y., Yang D.Q. Phosphorylation of eIF-4E positively regulates formation of the eIF-4F translation initiation complex following DNA damage. Biochem. Biophys. Res. Commun. 2008, 367:54-59.
51. Milner R., Crocker S.J., Hung S., Wang X., Frausto R.F., del Zoppo G.J. Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins alpha5beta1 and alphavbeta5. J. Immunol. 2007, 178:8158-8167.